Alyeska Investment Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.18M | Buy |
+50,000
| New | +$2.18M | 0.01% | 477 |
|
|
2022
Q2 | – | Sell |
-183,750
| Closed | -$7.78M | – | 618 |
|
|
2022
Q1 | $7.78M | Buy |
183,750
+57,457
| +45% | +$2.43M | 0.09% | 237 |
|
|
2021
Q4 | $8.02M | Buy |
126,293
+1,293
| +1% | +$82.1K | 0.09% | 212 |
|
|
2021
Q3 | $7.34M | Buy |
+125,000
| New | +$7.34M | 0.09% | 255 |
|